Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination.
Vitali
V
Pool
Daniel M
DM
Gordon
Michael
M
Decker
D005260:Female; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000276:immunology*; D015004:Yellow Fever / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000276:immunology*
D022341:Yellow Fever Vaccine